Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio

M. Mokhtarani, G. A. Diaz, W. Rhead, S. A. Berry, U. Lichter-Konecki, A. Feigenbaum, A. Schulze, N. Longo, J. Bartley, W. Berquist, R. Gallagher, W. Smith, S. E. McCandless, C. Harding, D. C. Rockey, J. M. Vierling, P. Mantry, M. Ghabril, R. S. Brown, K. DickinsonT. Moors, C. Norris, D. Coakley, D. A. Milikien, S. C. Nagamani, C. LeMons, B. Lee, B. F. Scharschmidt

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint Dive into the research topics of 'Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds